Clinical Trial Update: A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and pharmacology of GDC-0941 in combination with erlotinib in patients with advanced solid tumors, including non-squamous no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)
• GDC-0941 (GDC-0941)

Snippet

Sponsor: Genentech, Inc. | Conditions: Non-Squamous Non-Small Cell Lung Cancer, Solid Cancers | Phase 1 | Status: COMPLETED